← The Wire
EWTXNasdaq
Edgewise Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1710072
Edgewise Therapeutics discovers and develops precision medicines targeting key muscle proteins for serious muscle diseases
⚡ Elevated coverage
$3.75B
Market cap
$40.92
Last close
-1.3%
1D
+12.1%
5D
1.9M
Volume
Price · last 39 sessions+30.1%
May 4L $31.43 · H $42.30Jun 29
107
Total filings
Jun 5, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 5, 20268-KMaterial AgreementJun 1, 20268-KResults of OperationsMay 7, 202610-Q10-QMay 7, 2026SC 13D/ASC 13D/AApr 27, 2026DEFA14ADEFA14AApr 23, 2026DEF 14ADEF 14AApr 23, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 20268-KExecutive ChangeNov 20, 20258-KExecutive Change · Reg FD DisclosureNov 10, 202510-Q10-QNov 6, 20258-KResults of OperationsNov 6, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KReg FD Disclosure · Company UpdateJun 26, 2025DEFA14ADEFA14AMay 14, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 2025424B5424B5Apr 2, 20258-KMaterial Agreement · Reg FD DisclosureApr 2, 20258-KReg FD Disclosure · Company UpdateApr 2, 202510-K10-KMar 3, 20258-KResults of OperationsMar 3, 20258-KExecutive ChangeJan 22, 20258-KReg FD Disclosure · Company UpdateDec 16, 2024SC 13GSC 13GNov 14, 2024SC 13GSC 13GNov 8, 202410-Q10-QNov 7, 20248-KResults of OperationsNov 7, 2024SC 13GSC 13GOct 22, 20248-KExecutive ChangeAug 12, 202410-Q10-QAug 8, 20248-KResults of OperationsAug 8, 20248-KBylaw Amendment · Shareholder VoteJun 11, 20248-KMaterial Agreement · Agreement TerminatedMay 10, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024DEFA14ADEFA14AMay 7, 20248-KExecutive ChangeMay 7, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 202410-K10-KFeb 22, 20248-KResults of OperationsFeb 22, 2024SC 13GSC 13GFeb 2, 2024SC 13GSC 13GJan 29, 2024424B5424B5Jan 19, 20248-KMaterial Agreement · Reg FD DisclosureJan 19, 20248-KResults of Operations · Company UpdateJan 19, 202410-Q10-QNov 9, 20238-KResults of OperationsNov 9, 202310-Q10-QAug 10, 20238-KResults of OperationsAug 10, 20238-KDelisting NoticeJul 14, 20238-KDelisting Notice · Executive ChangeJun 22, 20238-KMaterial Agreement · Agreement TerminatedJun 16, 2023424B5424B5Jun 16, 20238-KShareholder VoteJun 12, 202310-Q10-QMay 11, 20238-KResults of OperationsMay 11, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 20238-KExecutive ChangeMar 6, 202310-K10-KFeb 23, 20238-KResults of OperationsFeb 23, 20238-KResults of OperationsNov 3, 202210-Q10-QNov 3, 2022SC 13GSC 13GSep 26, 2022SC 13GSC 13GSep 23, 20228-KMaterial AgreementSep 14, 2022424B5424B5Sep 14, 2022424B5424B5Sep 13, 20228-KCompany UpdateSep 13, 202210-Q10-QAug 4, 20228-KResults of OperationsAug 4, 20228-KShareholder VoteJun 24, 202210-Q10-QMay 11, 20228-KResults of OperationsMay 11, 2022
Insider Activity
In the 90 days to Mar 31, 2026: 2 sold $4.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 31, 2026 | Donovan Joanne M.CMO | Sell | 21,338 | $32.12 | $685K |
| Mar 27, 2026 | Donovan Joanne M.CMO | Sell | 9,623 | $30.98 | $298K |
| Mar 27, 2026 | Donovan Joanne M.CMO | Sell | 6,735 | $30.98 | $209K |
| Jan 21, 2026 | Edris BadreddinDirector | Sell | 66,477 | $29.44 | $2.0M |
| Jan 21, 2026 | Edris BadreddinDirector | Sell | 17,236 | $29.44 | $507K |
| Jan 21, 2026 | Edris BadreddinDirector | Sell | 13,690 | $29.44 | $403K |
| Jan 21, 2026 | Edris BadreddinDirector | Sell | 10,463 | $29.44 | $308K |
| Jan 21, 2026 | Edris BadreddinDirector | Sell | 7,605 | $29.44 | $224K |
| Nov 12, 2025 | Russell Alan JChief Scientific Officer | Sell | 100,000 | $21.12 | $2.1M |
| Nov 11, 2025 | Fox Jonathan CDirector | Buy | 10,700 | $18.64 | $199K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
⚡ Elevated coverageCoverage (30d): 2 reputable articles.
Investor's Business DailyBiotech Whips Violently Between Red And Green — What's Going On?14d agoInvestor's Business DailyHow Edgewise Sweetened Its Coffers By $1.55 Billion, And Removed A Key Overhang28d ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance